Abstract. Cilnidipine, a dihydropyridine Ca 2+ channel antagonist, is known to have inhibitory effects on both L-and N-type Ca 2+ currents. In the present study, we examined the effect of cilnidipine on myocardial L-and T-type Ca 2+ currents and sinoatrial node action potential configuration. In voltage clamped guinea pig ventricular myocytes, cilnidipine concentrationdependently decreased L-and T-type Ca 2+ currents. In rabbit sinoatrial node tissue, cilnidipine increased cycle length through reduction of phase 4 depolarization slope. In conclusion, cilnidipine has inhibitory effects on T-type Ca 2+ current, which may contribute to its negative chronotropic potency.
Cilnidipine is a 1,4-dihydropyridine derivative that blocks both L-and N-type Ca 2+ channels (1) . It has been reported to have excellent clinical profiles: its hypotensive action is slow in onset and long lasting (2) and is accompanied by renal protective effects (3, 4) . The reflex tachycardia produced by cilnidipine is less pronounced than that produced by other dihydropyridine Ca 2+ blockers such as nisoldipine in hypertensive patients (5) , dogs (2) , and rats (6) . The reduced reflex tachycardia has been attributed to inhibition of norepinephline release from sympathetic nerve terminals through N-type Ca 2+ channel blockade. Cilnidipine was also found to have high negative chronotropic potency in in vitro experiments with isolated heart preparations. In isolated atria from guinea pig, the ratio of the negative chronotropic / negative inotropic potencies (EC 25 for inotropism / EC 25 for chronotropism) of cilnidipine and nifedipine were 21.3 and 0.8, respectively; thus the selectivity for chronotropy was about 27 times higher for cilnidipine (7) . This selective chronotropic effect of cilnidipine in vitro provided another explanation for the reduced reflex tachycardia after cilnidipine administration in vivo, and also suggested that factors other than inhibition of L-and N-type Ca 2+ currents might be involved in its effect on the sinoatrial node.
The T-type Ca 2+ channel participates in cardiac pacemaking, regulation of vascular tone, and hormone secretion. It has electrophysiological characteristics different from those of the L-type Ca 2+ channel and is resistant to classical dihydropyridine Ca 2+ blockers (8) . We have been studying the myocardial effects of Ca 2+ blockers and found that efonidipine, a 1,4-dihydropyridine Ca 2+ channel blocker, has inhibitory effects on both L-and T-type Ca 2+ currents. Action potential measurements of the sinoatrial node revealed that efonidipine reduces the slope of phase 4 depolarization (pacemaker depolarization), which underlies its potent negative chronotropic effect (9, 10) . Further studies led to the conclusion that addition of T-type Ca 2+ channel blocking activity to dihidropyridine Ca 2+ blockers would lead to improvement of their clinical profiles (11) . In the case of cilnidipine, whether the drug has an inhibitory effect on the T-type Ca 2+ channel has not yet been clarified. In the present study, we examined whether cilnidipine has inhibitory effects on the T-type Ca 2+ current in isolated ventricular myocytes from the guinea pig. We also examined the effect of cilnidipine on rabbit sinoatrial node action potential with standard microelectrode techniques.
The present study was conducted in accordance with the Guiding Principles for the Care and Use of Laboratory Animals Approved by The Japanese Pharmacological Society. Ventricular cardiomyocytes were obtained from Hartley strain guinea pigs as previously *Corresponding author. FAX: +81-47-472-2113 E-mail: htanaka@phar.toho-u.ac.jp described (9) . Membrane currents of isolated ventricular cells were recorded with standard whole-cell voltage clamp techniques. For L-and T-type Ca 2+ currents measurements, the external solution was of the following composition: 120 mM TEA-Cl, 4 mM CsOH, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM glucose, and 5 mM HEPES (pH 7.4); for T-type Ca 2+ currents measurement, tetrodotoxin (30 m M) was added. The pipette solution contained had following composition: 80 mM CsCl, 40 mM CsOH, 5 mM ATP-Mg, 10 mM EGTA, and 10 mM HEPES (pH 7.4). The amplitude of the peak Land T-type Ca 2+ currents was determined as the difference between the peak inward current and the current at the end of the depolarizing pulse. The Ca 2+ currents were measured at room temperature (20 -23°C). The patch pipettes had resistance of 2 -4MW when filled with the internal solutions. Data acquisition and analysis were performed with a patch-clamp amplifier (Axopatch-1D; Axon Instruments, Foster City, CA, USA), a personal computer (Deskpro 486s; Compac, Houston, TX, USA) and pCLAMP software (Axon Instruments).
The transmembrane potential of the sinoatrial node preparation was measured as described previously (9) . Male Japanese white rabbits, weighing 2.0 -2.5 kg were anesthetized with sodium pentobarbital (30 mg / kg) and the hearts were quickly isolated. Tissues including the sinoatrial node were cut perpendicularly to the crista terminals into strips of about 1´3 mm and placed in a 20-ml organ bath filled with oxygenated (95% O 2 , 5% CO 2 ) and warmed (35.5 ± 0.5°C) physiological salt solution of the following composition: 118.4 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 24.9 mM NaHCO 3 , and 11.1 mM glucose. Action potentials were recorded with glass microelectrodes filled with 3 M KCl (resistance 20 -50 MW) and a microelectrode amplifier (MEZ-8201; Nihon Kohden, Tokyo). The action potential parameters measured were cycle length, maximum diastolic potential, threshold potential, maximum rate of rise, overshoot, action potential duration at 50% amplitude, and slope of the pacemaker (phase 4) depolarization.
Cilnidipine was kindly provided by Ajinomoto Co., Inc. (Kawasaki). Nifedipine was purchased from Sigma (St. Louis, MO, USA). Cilnidipine and nifedipine were dissolved in 100% dimethyl sulfoxide. The final concentration of dimethyl sulfoxide in the preparation bath (<0.1%) did not affect the electrophysiological and mechanical responses. All other chemicals were commercial products of the highest quality available. All data were presented as the mean ± S.E.M. Statistical significance between means was evaluated by the paired t-test. P values less than 0.05 were considered significant.
T-type Ca
2+ current was elicited every 5 s by 200-ms depolarizing test pulses from a holding potential of -90 to -30 mV; the peak inward current had a density of -1.1 ± 0.14 pA/ pF (n = 18) and was completely inhibited by 40 m M Ni
2+
. L-type Ca 2+ current was elicited every 5 s by 300-ms depolarizing test pulses from a holding potential of -40 to +10 mV; the peak inward current density at +10 mV was -5.1 ± 0.75 pA / pF (n = 17, Fig. 1A) .
Nifedipine selectively inhibited L-type Ca 2+ current; 0.1 mM nifedipine almost completely inhibited the Ltype Ca 2+ current, while 10 m M had almost no effect on the T-type Ca 2+ current. In contrast, cilnidipine had inhibitory effects on not only L-but also T-type Ca (Fig. 1B) . Concentration-response relation for the inhibitory effects of cilnidipine and nifedipine on Land T-type Ca 2+ currents are shown in Fig. 1B . Nifedipine selectively inhibited L-type Ca 2+ current, while cilnidipine had inhibitory effects on not only L-but also T-type Ca 2+ current. The configuration of spontaneous action potential of sinoatrial node preparations was the same as that in our previous report (9) . Cilnidipine (10 nM) prolonged the cycle length to about 113% of control values, accompanied by changes in action potential parameters ( Fig. 2; Table 1 ). Cilnidipine decreased the slopes of the early and late halves of pacemaker depolarization and shifted maximum diastolic potential to the positive direction. In the presence of Ni 2+ , cilnidipine had no significant effect on the cycle length and slope (Fig. 2 , Table 1 ).
The concentration-dependent blockade of both L-type and T-type Ca 2+ currents by cilnidipine was in contrast to the effect of nifedipine, which blocked only the Ltype Ca 2+ current. The potencies of cilnidipine for both currents were almost the same as those of efonidipine shown in our previous report (10) . The T-type Ca 2+ current has been reported to be present in the sinoatrial node and to play an important role in the late phase 4 74.7 ± 3.9 75.3 ± 5.6 Maximum rate of rise (+Vmax, V /s) 9.8 ± 0.9 10.0 ± 1.9 Threshold potential (mV) -41.7 ± 1. depolarization. Ni 2+ (40 to 50 mM), which selectively inhibits the T-type Ca 2+ current, was demonstrated to prolong the later half of phase 4 depolarization (12) . Similar changes in action potential waveform was observed after application of efonidipine or mibefradil, which blocks both L-and T-type Ca 2+ channels (9 -11) . In the present study, cilnidipine, which inhibited both L-and T-type Ca 2+ currents (Fig. 1) , decreased the slope of the sinoatrial node pacemaker depolarization (Fig. 2) : the percentage of inhibition was greater for the late phase than the early phase (Table 1) . Thus, the inhibitory effect of cilnidipine on T-type Ca 2+ channels, in addition to its inhibitory effect on L-and N-type Ca 2+ channels, may contribute to the characteristic changes in sinoatrial node action potential waveform and reduced reflex tachycardia on application of the drug in vivo. The observasion that such changes were not observed in the presence of Ni 2+ (Fig. 2 , Table 1 ) also support this view.
In hypertensive patients with benign nephrosclerosis, cilnidipine was reported to reduce albuminuria and the effect was comparable to that of benazepril, an angiotensin converting enzyme inhibitor (4). It has also been reported that cilnidipine dilated both afferent and efferent arterioles in rats with hydronephrosis, while standard dihydropyridines, which inhibit only L-type Ca 2+ channel, dilated only the afferent arterioles (3). Thus, it is likely that cilnidipine exerts glomelular protective effects through reduction of intraglomerular pressure. This characteristic effect of cilnidipine on renal microcirculation has been attributed to reduction of sympathetic nerve-mediated vasoconstriction through N-type Ca 2+ channel blockade by the drug (13) . On the other hand, T-type Ca 2+ channels have been shown to be involved in the regulation of efferent arteriolar tone (14) . Mibefradil and efonidipine, which blocks both Land T-type Ca 2+ channels, dilated both afferent and efferent arterioles to the same degree (14) . Thus, the Ttype Ca 2+ current inhibitory activity of cilnidipine, found in the present study, may partly contribute to the glomerular protective effect of the drug.
In conclusion, cilnidipine, which was known for its blocking action on L-and N-type Ca 2+ channels, was shown to block myocardial T-type Ca 2+ channel and prolong phase 4 depolarization of sinoatrial node action potential. Blockade of T-type Ca 2+ channel by cilnidipine may provide another explanation for its characteristic in vivo profiles such as minimum reflex tachycardia and reduced proteinuria.
